The involvement of PAX5 in other malignant B cell tumors, such as non-Hodgkin lymphomas and acute lymphoblastic leukemias, has been described as a dysregulation provoked by chromosomal translocations due to somatic hypermutation (SHM) and class-switch recombination [6,7,8]. This evidence concerns the gene PAX5 and acute lymphoblastic leukemia.